S1PR3 and breast neoplasm: Since activation of S1P3 is known to contribute to the development and aggressiveness of breast tumors, we investigated whether antagonism of S1P3 with 7H9 could inhibit the progression of human breast tumor xenografts in mice (Figure 5).